These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 17092396)

  • 1. The era of radical incrementalism?
    Sledge GW
    Clin Breast Cancer; 2006 Oct; 7(4):305. PubMed ID: 17092396
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent advances in the hormonal treatment of breast cancer.
    Boughey JC; Buzdar AU; Hunt KK
    Curr Probl Surg; 2008 Jan; 45(1):13-55. PubMed ID: 18206436
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inflammatory breast cancer: clinical course, diagnosis and treatment].
    Borisov VI; Chkhikvadze TV
    Vopr Onkol; 2008; 54(1):86-9. PubMed ID: 18416065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression models for the mean of the quality-of-life-adjusted restricted survival time using pseudo-observations.
    Andrei AC; Murray S
    Biometrics; 2007 Jun; 63(2):398-404. PubMed ID: 17688492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome of breast conservation therapy for breast cancer in Hong Kong: prognostic impact of ipsilateral breast tumor recurrence and 2005 St. Gallen risk categories.
    Yau TK; Soong IS; Chan K; Chan M; Cheung P; Lau HW; Chang AT; Lee AW
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):667-72. PubMed ID: 17379441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary endocrine therapy in locally advanced breast cancers--the Nottingham experience.
    Mathew J; Agrawal A; Asgeirsson KS; Buhari SA; Jackson LR; Cheung KL; Robertson JF
    Breast Cancer Res Treat; 2009 Jan; 113(2):403-7. PubMed ID: 18311583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The assessment of subgroups in clinical trials.
    Cuzick J
    Experientia Suppl; 1982; 41():224-35. PubMed ID: 6958512
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic options for Paget's disease: A single institution long-term follow-up study.
    Joseph KA; Ditkoff BA; Estabrook A; El-Tamer MB; Banarjee S; Schnabel FR
    Breast J; 2007; 13(1):110-1. PubMed ID: 17214812
    [No Abstract]   [Full Text] [Related]  

  • 9. How important is the axillary nodal status for adjuvant treatment decisions at a breast cancer multidisciplinary tumor board? A survival analysis.
    Reimer T; Fietkau R; Markmann S; Stachs A; Gerber B
    Ann Surg Oncol; 2008 Feb; 15(2):472-7. PubMed ID: 17987339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved survival of patients with metastatic breast cancer in routine care: results of a retrospective study in a community-based oncology group practice 1995-2005.
    Weide R; Mergenthaler U; Pandorf A; Arndt H; Heymanns J; Thomalla J; Köppler H
    Onkologie; 2009 Mar; 32(3):107-13. PubMed ID: 19295249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical treatment for older breast cancer patients].
    Osaki A; Saeki T
    Gan To Kagaku Ryoho; 2007 Mar; 34(3):374-9. PubMed ID: 17353627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated partial breast irradiation.
    Yadav BS
    Radiother Oncol; 2009 Jan; 90(1):161. PubMed ID: 17963907
    [No Abstract]   [Full Text] [Related]  

  • 13. Aromatase inhibitors as adjuvant therapy for breast cancer: overall survival versus disease-free survival as a primary end point in clinical practice.
    Sánchez-Muñoz A; Ribelles N; Márquez A; Pérez-Ruiz E; Alba E
    J Clin Oncol; 2009 Dec; 27(35):e255-6; author reply e257-8. PubMed ID: 19884520
    [No Abstract]   [Full Text] [Related]  

  • 14. Breast cancer patients with 10 or more involved axillary lymph nodes treated by multimodality therapy: influence of clinical presentation on outcome.
    Geara FB; Nasr E; Tucker SL; Charafeddine M; Dabaja B; Eid T; Abbas J; Salem Z; Shamseddine A; Issa P; El Saghir N
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):364-9. PubMed ID: 17324529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer: beyond the cutting edge.
    Higa GM
    Expert Opin Pharmacother; 2009 Oct; 10(15):2479-98. PubMed ID: 19761355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized trial.
    Adjuvant Breast Cancer Trials Collaborative Group
    J Natl Cancer Inst; 2007 Apr; 99(7):506-15. PubMed ID: 17405995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999.
    Blamey RW; Ellis IO; Pinder SE; Lee AH; Macmillan RD; Morgan DA; Robertson JF; Mitchell MJ; Ball GR; Haybittle JL; Elston CW
    Eur J Cancer; 2007 Jul; 43(10):1548-55. PubMed ID: 17321736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year survival from breast cancer in Western Australia over a decade.
    Clayforth C; Fritschi L; McEvoy SP; Byrne MJ; Ingram D; Sterrett G; Harvey JM; Joseph D; Jamrozik K
    Breast; 2007 Aug; 16(4):375-81. PubMed ID: 17448661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic therapy of metastatic breast cancer: the truth beyond the clinical trials.
    Gueth U; Huang DJ; Schoetzau A; Holzgreve W; Wight E
    Oncology; 2009; 76(4):247-53. PubMed ID: 19246949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time trends in the outcome of elderly patients with breast cancer.
    Hughes S; Barbachano Y; Ashley S; Yap YS; Popat S; Allen M; Della-Rovere UQ; Johnston S; Smith I; O'Brien M
    Breast J; 2008; 14(2):158-63. PubMed ID: 18312470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.